Doxorrubicin
Showing 1 - 7 of 7
Advanced Soft-tissue Sarcoma Trial (LB-100 plus Doxorrubicin, Doxorubicin)
Not yet recruiting
- Advanced Soft-tissue Sarcoma
- LB-100 plus Doxorrubicin
- Doxorubicin
- (no location specified)
Apr 11, 2023
Breast Cancer Trial in Brazil (Docetaxel or Paclitaxel, Cyclophosphamide + Doxorrubicin)
Recruiting
- Breast Cancer
- Docetaxel or Paclitaxel
- Cyclophosphamide + Doxorrubicin
-
Goiânia, Goiás, Brazil
- +9 more
Jan 5, 2023
BRCA1 Hereditary Breast and Ovarian Cancer Syndrome Trial in Barretos (Doxorubicin, Carboplatin, Paclitaxel)
Completed
- BRCA1 Hereditary Breast and Ovarian Cancer Syndrome
- Doxorubicin
- +3 more
-
Barretos, SP, BrazilBarretos Cancer Hospital
Dec 25, 2022
Locally Advanced HER2-positive Breast Cancer Trial in Sao Paulo (Drug: Paclitaxel; trastuzumab; doxorrubicin; cyclophosphamide)
Terminated
- Locally Advanced HER2-positive Breast Cancer
- Drug: Paclitaxel; trastuzumab; doxorrubicin; cyclophosphamide
-
Sao Paulo, BrazilInstituto do Cancer do Estado de Sao Paulo
May 20, 2014
Multiple Myeloma Trial in Brazil (Thalidomide plus dexamethasone, Dexamethasone)
Completed
- Multiple Myeloma
- Thalidomide plus dexamethasone
- Dexamethasone
-
Campinas, São Paulo, Brazil
- +3 more
Feb 14, 2011